Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age40+
SponsorMarmara University

About this trial

This study will look at how well a measure called the Qmax/eGFR ratio is related to the severity of urination problems in men over the age of 40. Qmax is a test that shows how fast a person can urinate, and eGFR is a number that reflects kidney function. Men who have urinary symptoms will be asked to do a urine flow test, a blood test, and fill out a questionnaire about their symptoms and quality of life. We will study if there is a link between the Qmax/eGFR ratio and how severe their symptoms are. The results may help doctors better understand how kidney and urinary function are related in men with these problems.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male patients aged 40 years or older presenting with lower urinary tract symptoms (LUTS)

Able to provide informed consent

Willing and able to undergo uroflowmetry and blood testing

Able to complete the IPSS questionnaire, including the QoL item

Disqualifiers

History of urological surgery (e.g., prostatectomy, bladder surgery)

Diagnosed or suspected prostate cancer

Active urinary tract infection (based on clinical symptoms or urinalysis)

Neurological conditions affecting bladder function (e.g., Parkinson's disease, spinal cord injury)

Trial population

Male outpatients aged 40 years or older who present with lower urinary tract symptoms (LUTS) to the urology clinic. Participants will be evaluated during routine clinical visits and must be capable of completing symptom questionnaires and undergoing non-invasive tests such as uroflowmetry and blood sampling. The study population is drawn from a single tertiary academic medical center.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

100 Participants
are grouped into 1 trial group
Group A: Men Over 40 With LUTS

Trial outcomes

Primary outcomes

1

Correlation Between Qmax/eGFR Ratio and Total IPSS Score

This outcome assesses the statistical correlation between the Qmax/eGFR ratio and the total International Prostate Symptom Score (IPSS). Pearson or Spearman correlation analysis will be used to evaluate the relationship between the ratio and LUTS severity.

Time frame
At baseline
2

Correlation Between Qmax/eGFR Ratio and IPSS Quality of Life Subscore

This outcome evaluates the correlation between the Qmax/eGFR ratio and the IPSS Quality of Life (QoL) subscore, aiming to assess the association between voiding/renal parameters and patient-perceived well-being.

Time frame
At baseline

Secondary outcomes

1

Factors Associated With Qmax/eGFR Ratio

This outcome aims to identify clinical factors that may influence the Qmax/eGFR ratio in men over 40 with lower urinary tract symptoms. Variables to be analyzed may include age, prostate volume, voided volume, and average flow rate (Qave), among others. Multivariable analysis will be performed to explore independent associations.

Time frame
At baseline
2

Association of Clinical Variables With Qmax/eGFR Ratio

This analysis will identify clinical parameters independently associated with Qmax/eGFR ratio, including age, prostate volume, voided volume, and average flow rate (Qave). Multivariable regression models will be used to determine significant predictors.

Time frame
At baseline

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: